Stephan Lanes
Stephan Lanes
Principle Scientist
Email confirmado em
Citado por
Citado por
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients
SM Curkendall, C DeLuise, JK Jones, S Lanes, MR Stang, E Goehring Jr, ...
Annals of epidemiology 16 (1), 63-70, 2006
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program
S Sidney, M Sorel, CP Quesenberry Jr, C DeLuise, S Lanes, MD Eisner
Chest 128 (4), 2068-2075, 2005
The reporting odds ratio and its advantages over the proportional reporting ratio
KJ Rothman, S Lanes, ST Sacks
Pharmacoepidemiology and drug safety 13 (8), 519-523, 2004
Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis
CJ Mercaldi, SF Lanes
Chest 143 (2), 532-538, 2013
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients
JO Stern, PA Robinson, J Love, S Lanes, MS Imperiale, DL Mayers
JAIDS Journal of Acquired Immune Deficiency Syndromes 34, S21-S33, 2003
A metaregression analysis of the dose-response effect of aspirin on stroke
ES Johnson, SF Lanes, CE Wentworth, MH Satterfield, BL Abebe, ...
Archives of internal medicine 159 (11), 1248-1253, 1999
Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting. The importance of drug and surgery costs
SF Lanes, LL Lanza, PW Radensky, RA Yood, RF Meenan, AM Walker, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
Pooled clinical trial analysis of tiotropium safety
S Kesten, M Jara, C Wentworth, S Lanes
Chest 130 (6), 1695-1703, 2006
Burden of illness in idiopathic pulmonary fibrosis
HR Collard, AJ Ward, S Lanes, D Cortney Hayflinger, DM Rosenberg, ...
Journal of medical economics 15 (5), 829-835, 2012
A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch
S Greenland, MH Satterfield, SF Lanes
Drug Safety 18 (4), 297-308, 1998
The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials
SF Lanes, JE Garrett, CE Wentworth III, JM Fitzgerald, JP Karpel
Chest 114 (2), 365-372, 1998
Chronic obstructive pulmonary disease severity and cardiovascular outcomes
SM Curkendall, S Lanes, C de Luise, MR Stang, JK Jones, D She, ...
European journal of epidemiology 21, 803-813, 2006
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam
G Singh, S Lanes, G Triadafilopoulos
The American journal of medicine 117 (2), 100-106, 2004
Guidelines for good pharmacoepidemiology practice (GPP)
Public Policy Committee, International Society of Pharmacoepidemiology
Pharmacoepidemiology and Drug Safety 25 (1), 2-10, 2016
Respiratory medications and risk of asthma death
SF Lanes, LAG Rodriguez, C Huerta
Thorax 57 (8), 683-686, 2002
Respiratory medications and the risk of cardiac arrhythmias
C Huerta, SF Lanes, LAG Rodríguez
Epidemiology 16 (3), 360-366, 2005
Idiopathic pulmonary fibrosis in United States automated claims. Incidence, prevalence, and algorithm validation
DB Esposito, S Lanes, M Donneyong, CN Holick, JA Lasky, D Lederer, ...
American journal of respiratory and critical care medicine 192 (10), 1200-1207, 2015
Oral contraceptive type and functional ovarian cysts
SF Lanes, B Birmann, AM Walker, S Singer
American journal of obstetrics and gynecology 166 (3), 956-961, 1992
Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
JE Garrett, SF Lanes, J Kolbe, HH Rea
Thorax 51 (11), 1093-1099, 1996
Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation
S Greenland, S Lanes, M Jara
Clinical Trials 5 (1), 5-13, 2008
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20